U.S. FDA asks J&J to discard millions of COVID -19 vaccine doses
The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID -19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use.
3 minute readBoxes of the Johnson & Johnson COVID-19 vaccine are seen at the McKesson Corporation, amid the coronavirus disease outbreak, in Shepherdsville, U.S., March 1, 2021. Timothy D. Easley/Pool via REUTERS/File PhotoThe U.S. Food & Drug Administration on Friday said Johnson & Johnson
(JNJ.N)must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use.Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses. The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter.
Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated.The agency said it was not yet ready to authorize Emergent BioSolutions Inc's headtopics.com
(EBS.N)plant for manufacturing the J&J vaccine. Production of J&J's vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant.One source familiar with the matter told Reuters that the J&J doses are expected to be exported to other countries. The doses are already in vials and ready for use, the other source said.
Safety concerns about the J&J vaccine paired with flagging U.S. demand for vaccinations in general have slowed rollout of the one-shot vaccine to a crawl. Close to half of the 21 million doses produced for the United States sit unused.read moreThe FDA said its decision allows for the J&J doses to be used in the United States or exported. The agency said the drugmaker and Emergent must agree that the FDA can share relevant information about the manufacturing of the doses with regulators where the vaccine is shipped.
J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed."Today's decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale," Kathy Wengel, J&J's chief global supply chain officer, said in the statement.
The FDA declined to comment beyond its statement. Read more: Reuters Top News »
Jeff Bezos' spaceflight: Live updates
Jeff Bezos will fly to space today on the first crewed flight of the New Shepard, the rocket ship made by his space company, Blue Origin. Follow here for live updates.
For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to her Alex_jnns01 Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success
FDA tells Johnson & Johnson to toss 60 million Covid vaccine dosesThe FDA has told Johnson & Johnson to discard about 60,000,000 doses of its Covid-19 vaccine that were produced at a troubled plant in Baltimore, according to 2 people familiar with the matter. matteroffacttv 60 million people waiting longer for vax.
Johnson & Johnson says FDA has extended shelf life of single-dose COVID vaccine by six weeksOriginal three-month expiration dates loomed at end of June. It’s better to get sick and trust drugs that have been around for years. These Vaccines are experimental. These vaccines are more dangerous than getting covid and getting Hydroxychoroquine also it is more effective against Covid-19 than the vaccines.
Moderna Asks FDA For Emergency Approval Of Its Covid-19 Vaccine In Teens Aged 12-17Moderna announced that it has filed a request with the FDA for Emergency Use Authorization of its Covid-19 vaccine in teens aged 12-17
Moderna seeks FDA authorization for Covid-19 vaccine for people ages 12 to 17Moderna has filed with the US Food and Drug Administration for emergency use authorization for its Covid-19 vaccine for people ages 12 to 17, according to a news release from the company.
Moderna’s Covid-19 Vaccine Seeks FDA Authorization for Use in AdolescentsModerna asked the FDA to authorize expanding the use of its Covid-19 vaccine to people as young as 12. The application means Moderna’s shot could be cleared for use in the older children this summer. 157,076,436 of 174,054,973 global covid-19 CASES recovered. Covid-19 CASES recover because they have natural efficacious immunoglobulin. So find out if you're immunoglobulin efficacy POSITIVE. Ask which (IET) covid-19 immunoglobulin efficacy test is right for you. There's a deafening silence around discussing natural immunoglobulin efficacy. Allopathic medical leaders recognised this efficacy in asymptomatic super spreaders. Why won't front line allopathic experts investigate how asymptomatics' efficacious immunoglobulin repels covid-19?
Biden and Johnson expected to commit to lifting US-UK Covid-19 travel restrictionsCNN News, delivered. Select from our newsletters below and enter your email to subscribe. They asked for my opinion, only because they found me interesting.